Neurovalens Initiates VeNS Trial for Adolescent Anxiety Treatment
Neurovalens Ltd. is conducting a randomized trial to assess the efficacy of Electrical Vestibular Stimulation for Generalized Anxiety Disorder in adolescents.
Asset / Drug
Drug and asset intelligence for Neurovalens with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.